Current controversies in the management of patent ductus arteriosus in preterm infants

Indian Pediatr. 2014 Apr;51(4):289-94. doi: 10.1007/s13312-014-0403-2.

Abstract

Objective: Patent ductus arteriosus is very commonly seen in very low birth weight (VLBW) infants, affecting about one-third. The present review tries to identify the group of VLBW infants who need active intervention in day-to-day practice and to determine the mode of intervention, based on current published literatures.

Methods: We searched the Cochrane library, MEDLINE, EMBASE and CINAHL databases, and reference that of identified trials.

Results and conclusions: Preterm infants with a birth weight of <800g are at risk of significant morbidity and mortality from PDA; it would be reasonable to treat them when symptomatic or if requiring positive pressure ventilator support. Those weighing >800g are unlikely to need treatment unless they are ventilator-dependent or show evidence of congestive heart failure.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cardiac Surgical Procedures
  • Cyclooxygenase Inhibitors
  • Ductus Arteriosus, Patent / therapy*
  • Humans
  • Infant, Newborn
  • Infant, Premature*
  • Infant, Very Low Birth Weight

Substances

  • Cyclooxygenase Inhibitors